YCX26ยท AIAbInitio Bio
The Intelligence layer for Drug Manufacturing
Founders
- Daniel MukasaFounder/CEO
- Nisha GopalFounder
Same space
Adjacent
Overlapping tags, a different niche.
CellTypeW26The agentic drug company. We simulate human biology.Shared: drug, validated, pharmaActive
Strand AIW26Multimodal foundation models to predict uncollected patient biologyShared: drug, bio, modelActive
Multiply LabsS16Robotic production capacity for the pharma manufacturing industryShared: manufacturing, drug, pharmaActive
Maquoketa ResearchX26The intelligence layer for dronesShared: layer, intelligenceActive
Lavo Life SciencesW23AI for drug formulationShared: drug, pharma, labInactive
Also from X26 in AI
Batchmates in Spring 2026.
Advanced Metal ResearchX26Machine intelligence for American WeldingActive
AgentPhoneX26Phone Numbers for AI AgentsActive
AkkariX26Autonomous Customer OperationsActive
AllowanceX26The spend control layer for AI agentsActive
AmborasX26AI Native ShopifyActive
AndcoX26Agents that build personal injury casesActive
About AbInitio Bio
Abinitio Bio builds foundation models for biomanufacturing, validated against wet lab data. Our first model, Echo, predicts manufacturing outcomes more accurately than standard models, and any pharma or CDMO can adapt it to their own workflow instantly. By making process decisions that take 6-18 months today in hours, we help teams avoid the cost of delay on a single program.
Boston, MA, USA
AbInitio Bio: questions
Which YC batch was AbInitio Bio in?
AbInitio Bio was in Y Combinator's Spring 2026 batch (X26).
Is AbInitio Bio still active?
Y Combinator lists AbInitio Bio as active.
Who founded AbInitio Bio?
AbInitio Bio's founders, as listed on its YC page: Daniel Mukasa (Founder/CEO), Nisha Gopal (Founder).
Where is AbInitio Bio based?
AbInitio Bio lists Boston, MA, USA as its location on YC's directory.
Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.